Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis.

导出 LinkOut

翻译打印收藏纠错

作者： Stephanie E,Chiuve ^[1] ; Daniel,Fife ^[2] ; Gerhard,Leitz ^[2] ; Craig,Peterson ^[3] ; Neil M,Campbell ^[4] ; Amanda,Rennig ^[4] ; Lino,Rodrigues ^[1] ; Dennis,Decktor ^[5] ; Christopher,Dowd ^[6] ; Bruce C,Marshall ^[6] ; Drucy,Borowitz ^[7]

作者单位： AbbVie Inc, 1 North Waukegan Rd, North Chicago, IL 60064, United States. ^[1] Janssen Research & Development, LLC, 1125 Trenton Harbourton Road, Titusville, NJ 08560, United States. ^[2] Vivus LLC, 900 E Hamilton Avenue, Suite 550, Campbell, CA 95008, United States. ^[3] Digestive Care, Inc, 1120 Win Drive, Bethlehem, PA 18017, United States. ^[4] Nestle, 1729 St. Georges Rd, Dresher, PA 19025, United States. ^[5] Cystic Fibrosis Foundation, 4550 Montgomery Ave., Suite 1100 N, Bethesda, MD 20814, United States. ^[6] Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 1001 Main Street, 5th Floor, Buffalo, NY 14203, United States. Electronic address: borowitz@buffalo.edu. ^[7]

关键词 Cohort study Cystic fibrosis Fibrosing colonopathy Pancreatic enzyme replacement therapy Pharmacoepidemiology

主题词人类(Humans);囊性纤维化(Cystic Fibrosis);发病率(Incidence);前瞻性研究(Prospective Studies);酶替代疗法(Enzyme Replacement Therapy);胰腺(Pancreas);纤维化(Fibrosis)

DOI 10.1016/j.jcf.2023.08.013

PMID 37880023

发布时间 2024-11-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交